Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine

Dermatol Ther. 2022 Mar;35(3):e15280. doi: 10.1111/dth.15280. Epub 2021 Dec 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • RNA, Messenger
  • SARS-CoV-2
  • Vitiligo*

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine